Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for delayed post-stroke cognitive impairment
ChiCTR2000032555Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of butylphthalide in post-stroke cognitive impairment (PSCI) (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Magnetic resonance imaging and Cognitive and psychosomatic correlation scales. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
post-stroke cognitive impairment (PSCI)
Beyond the preview
Go deeper on ChiCTR2000032555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032555.